Abstract: Pfizer and Amgen are among 22 strategic enterprises planning to open or expand offices in Hong Kong, signaling a substantial commitment to the city’s business ecosystem. Both firms are valued at over HK$1 trillion, underscoring expected growth and investment in Hong Kong.Pfizer and Amgen, among 22 strategic firms, plan to expand offices in Hong Kong, signaling major investment and growth, with valuations over HK$1 trillion.

NodeGuardian

2026-04-21 12:54:01

Abstract generation in progress

Pfizer and Amgen, global drug maker and biotech firm respectively, are reportedly among 22 strategic enterprises planning to open or expand offices in Hong Kong. Both companies are valued at over HK$1 trillion ($153 billion). This expansion signals significant investment and growth for these firms in the Hong Kong market.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
297.17K Popularity
#
Gate13thAnniversaryLive
751.4K Popularity
#
BitcoinBouncesBack
171.31K Popularity
#
USIranTalksProgress
877.68K Popularity
#
HKUnveilsNewCryptoRules
274.21K Popularity

Sitemap

Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE)

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

BitcoinBouncesBack

USIranTalksProgress

HKUnveilsNewCryptoRules

Pin